US Broker Ratings

SIGA Technologies Inc. (SIGA) Stock Analysis: Uncovering Potential Amidst Market Fluctuations

SIGA Technologies Inc. (NASDAQ: SIGA) stands at an intriguing intersection of opportunity and volatility within the healthcare sector. As a player in the specialty and generic..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 26.94% Upside Potential in Healthcare SaaS

HealthStream, Inc. (NASDAQ: HSTM) stands as a noteworthy player in the healthcare sector, offering a range of Software-as-a-Service (SaaS) solutions tailored to the evolving needs of..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 155% Potential Upside in Telehealth

LifeMD, Inc. (NASDAQ: LFMD), a key player in the burgeoning telehealth industry, is capturing the attention of investors with a compelling 155.17% potential upside, according to..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a Potential 220% Upside

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the health information services sector, presents an intriguing opportunity for investors willing to navigate its current financial..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Potential Upside Amidst Revolutionary Drug Discovery

Relay Therapeutics, Inc. (NASDAQ: RLAY), a trailblazer in the biotechnology sector, is captivating investor interest with its cutting-edge approach to drug discovery. Specializing in precision medicines,..

GH Research PLC (GHRS) Stock Analysis: Potential 42.96% Upside Draws Investor Attention

GH Research PLC (NASDAQ: GHRS) is making waves in the biotechnology sector with its promising pipeline of treatments for depression and other psychiatric disorders. For investors,..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a Potential 136.81% Upside in the Biotechnology Sector

REGENXBIO Inc. (NASDAQ: RGNX), a prominent player in the biotechnology sector, is drawing attention from investors with a market cap of $656.21 million and a promising..

Orthofix Medical Inc. (OFIX): Investor Outlook on a Healthcare Innovator with 41% Potential Upside

For investors with an eye on the healthcare sector, Orthofix Medical Inc. (NASDAQ: OFIX) presents a captivating opportunity. With a market capitalization of $443.02 million, this..

Tilray Brands, Inc. (TLRY) Stock Analysis: Navigating a 126.82% Potential Upside Amidst a Challenging Market

Tilray Brands, Inc. (NASDAQ: TLRY) holds a unique position within the healthcare sector, specifically in the drug manufacturers – specialty & generic industry. With a market..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: A Promising 82.55% Upside in the Biotech Arena

Cullinan Therapeutics, Inc. (CGEM), a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, is making waves in the healthcare sector, particularly within the biotechnology industry. With a..

Xencor (XNCR) Stock Analysis: Unlocking Potential with a 45% Upside Despite Current Challenges

For investors eyeing opportunities in the biotech sector, Xencor, Inc. (NASDAQ: XNCR) presents a compelling case with its significant potential upside, despite facing some current financial..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Growth in the Medical Devices Sector

Avanos Medical, Inc. (NYSE: AVNS) is a noteworthy player in the healthcare sector, particularly within the dynamic field of medical devices. With a market capitalization of..

Neuropace, Inc. (NPCE) Stock Analysis: Unpacking a 36% Upside Potential Amidst Challenges

Neuropace, Inc. (NPCE) is making waves in the healthcare sector, particularly within the medical devices industry. Known for its innovative RNS System, a brain-responsive neuromodulation system..

Rocket Pharmaceuticals (RCKT) Stock Analysis: Exploring a Potential 186% Upside in Genetic Therapy Innovation

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is capturing investor attention with its cutting-edge focus on genetic therapies for rare and life-threatening diseases. As a late-stage biotechnology company,..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Uncovering a Potential 125% Upside in the Biotech Sector

Taysha Gene Therapies, Inc. (TSHA), a promising player in the biotechnology industry, is capturing the attention of investors with its focus on groundbreaking adeno-associated virus-based gene..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Biotech Innovator with 17% Upside Potential

Investors with an interest in the biotechnology sector may find Sionna Therapeutics, Inc. (NASDAQ: SION) to be a compelling addition to their portfolios. This clinical-stage biopharmaceutical..

Butterfly Network, Inc. (BFLY) Stock Analysis: A Closer Look at the 25% Revenue Growth and Promising Analyst Ratings

Butterfly Network, Inc. (NASDAQ: BFLY) is making waves in the healthcare sector with its innovative approach to medical imaging. Specializing in handheld ultrasound devices, Butterfly Network..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a Potential 33.55% Upside in the Pediatric Orthopedic Market

OrthoPediatrics Corp. (NASDAQ: KIDS) is making waves in the healthcare sector, specifically within the niche of medical devices tailored for pediatric orthopedic conditions. As a company..

uniQure N.V. (QURE) Stock Analysis: Exploring a 63.82% Potential Upside in the Biotech Arena

uniQure N.V. (NASDAQ: QURE), a prominent player in the biotechnology sector, is carving a niche in revolutionary gene therapies aimed at rare and severe diseases. Headquartered..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Exploring a 40% Potential Upside

Amylyx Pharmaceuticals, Inc. (AMLX) stands as a notable contender within the healthcare sector, specifically among drug manufacturers specializing in both specialty and generic formulations. Based in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds